DIRS.INFO The most relevant business & tech news

☆ NIH to test Pfizer’s Paxlovid, other treatments as potential long Covid therapies
▼ + stars: | 2023-07-31 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +1 min

The National Institutes of Health said Monday it launched mid-stage clinical trials to test at least four treatments, including Pfizer 's antiviral Covid-19 pill Paxlovid, as potential therapies for long Covid. But the lack of a specific long Covid treatment pushes some patients to seek unproven – and potentially dangerous – remedies for the condition. "NIH is committed to a highly coordinated and scientifically rigorous approach to find treatments that will provide relief for the millions of people living with long COVID." The NIH will test the safety and effectiveness of the treatments – which include both drugs and medical devices – in groups of 100 to 300 patients with long Covid symptoms. The first part of the phase two trial will test a longer dosing regimen of Paxlovid to see if it improves long Covid symptoms.

Persons: Lawrence Tabak Organizations: National Institutes of Health, Pfizer, Health, NIH

☆ Op-ed: Gottlieb says A.I. may take on doctors' roles sooner than later
▼ + stars: | 2023-07-31 | by ( Scott Gottlieb | ) www.cnbc.com time to read: +7 min

The AI tools being applied to healthcare can generally be divided into two main categories. The first encompass large language models that are applied to administrative functions like processing medical claims or creating and analyzing medical records. In fact, up to 30 percent of radiology practices have already adopted AI tools. Right now, there are only a few clinical language models, and even the largest ones possess a relatively small number of parameters. As the quality and scope of clinical data available for training these large language models continue to grow, so will their capabilities.

Persons: Scott Gottlieb, ChatGPT, Amazon's, retinopathy, IBM's, Watson, they're, William J Organizations: CNBC, Pfizer, Aetion Inc, Cruise Line Holdings, Harvard, FDA, Oncology, Google, Healthcare

☆ This ETF is the best way to play a 'goldilocks' health-care sector, Bank of America says
▼ + stars: | 2023-07-28 | by ( Jesse Pound | In Jesse-Pound | ) www.cnbc.com time to read: +2 min

A health-care fund with a strong track record could be in a sweet spot for investors who are looking to take some risk off the table, according to Bank of America. "Since 2006, HCES has been a 'goldilocks' trade for investors looking for high-beta healthcare exposure without extreme volatility," the note said. The firm's top-rated ETF in the space is the iShares U.S. Medical Devices ETF (IHI) , which helps investors avoid the volatile biotech stocks found in broader health-care sector funds. IHI 5Y mountain The IHI has averaged a total return of more than 10% over the past five years. In our view, the trade is far less crowded than broad healthcare for investors looking for defensive exposure," Woodard said.

Persons: Jared Woodard, HCES, Woodard, — CNBC's Michael Bloom Organizations: Bank of America . Investment, Medical Devices, Fisher, Abbott Laboratories, Bank of America Locations: U.S

☆ ‘Smart tattoos’ injected into the skin could someday monitor your health
▼ + stars: | 2023-07-26 | by ( Samantha Bresnahan | ) edition.cnn.com time to read: +8 min

"Smart tattoo" ink shows up here as the blue dots, activated by UV light during testing at Carson Bruns' lab in Boulder, Colorado. “We hope our results will ultimately inform Magic Ink and all tattoo ink manufacturers how to optimize the biocompatibility of their pigments in due time. A “check-engine light”Researchers say one advantage of smart tattoos over wearable technology such as smart watches or glucose monitors is that they can’t be hacked or run out of battery. A tattoo artist in London practices with smart ink developed by researcher Ali Yetisen on a piece of pig skin. He envisions a future where astronauts could utilize smart tattoos in space to gauge radiation exposure, for infectious disease detection in the general public or to help monitor chronic disease.

Persons: ”, Ali Yetisen, ” Yetisen, Yetisen, “, Carson Bruns, American Cancer Society . Bruns, Bruns, Jesse Butterfield, don’t, ” Bruns, Wearables, Dr, Daniel Kraft, Kraft, you’ll, CNN’s Michelle Cohan Organizations: CNN, Department of Chemical Engineering, Imperial College London, Harvard Medical School, Harvard, MIT, American Cancer Society ., University of Colorado, FDA, Science Foundation Locations: University of Colorado Boulder, Boulder , Colorado, United States, Yetisen’s, London

☆ GE HealthCare raises 2023 profit forecast as supply chain woes ease
▼ + stars: | 2023-07-25 | by ( ) www.reuters.com time to read: +2 min

July 25 (Reuters) - GE HealthCare Technologies Inc (GEHC.O) raised its annual profit forecast on Tuesday, after beating quarterly earnings estimates due to easing supply chain issues that had largely impacted electronic components during the pandemic. Johnson & Johnson (JNJ.N) and Abbott Laboratories (ABT.N), which make medical devices like heart stents and implants, surpassed quarterly profit estimates last week as patients underwent their delayed procedures. GE HealthCare on Tuesday reported total quarterly sales of $4.8 billion, in line with analysts' estimates. Of this, $2.6 billion came from sales of imaging devices such as magnetic resonance imaging (MRI) and $839 million from ultrasound devices. The healthcare equipment firm operates four medical device businesses - imaging and ultrasound devices, patient care solutions and pharmaceutical diagnostics - with imaging being the largest.

Persons: Johnson, Khushi, Shailesh Organizations: GE HealthCare Technologies Inc, GE, Johnson, Abbott Laboratories, GE HealthCare, General Electric, Thomson Locations: Bengaluru

☆ Here are the only 4 global stocks to raise dividends by more than 10% for the past 15 years
▼ + stars: | 2023-07-25 | by ( Ganesh Rao | ) www.cnbc.com time to read: +3 min

Among the stocks screened by CNBC Pro, the 98-year-old firm offered the highest dividend yield at 3.3%. Dividend yield is calculated as the dividend per share divided by the share price. The dividend yield can go up if the share price drops, and conversely, the yield can drop if the share price goes up. The stock has risen 340% in price returns, which strips out dividend payments, over the past 15 years. If the stock price also appreciates, the total return for the investor (capital gains plus dividends) would be even higher.

Persons: Japan — Organizations: CNBC Pro, Atrion Corporation, Kerry Group Locations: Brussels, Africa, Japan

☆ J&J starts share exchange offer for consumer health spin-off Kenvue
▼ + stars: | 2023-07-24 | by ( ) www.reuters.com time to read: +1 min

[1/2] The Johnson & Johnson logo is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, U.S., May 29, 2019. REUTERS/Brendan McDermid/File PhotoJuly 24 (Reuters) - Johnson & Johnson (JNJ.N) said on Monday it had launched an exchange offer under which its stockholders can opt for shares of Kenvue <KVUE.N>, its newly listed consumer health unit. The exchange will allow J&J shareholders to exchange their shares for those of Kenvue at a 7% discount, subject to conditions. Kenvue, which debuted on the New York Stock Exchange in May, has a market capitalization of about $46 billion. ‍Goldman Sachs and J.P. Morgan Securities are serving as dealer managers for the offering, J&J said.

Persons: Johnson, Brendan McDermid, ‍ Goldman Sachs, J.P, J, Bhanvi, Shounak Dasgupta, Anil D'Silva Organizations: New York Stock Exchange, REUTERS, Johnson, Morgan Securities, Thomson Locations: New York, U.S, Kenvue, Bengaluru

☆ We're selling some shares of this health-care company and changing our rating
▼ + stars: | 2023-07-24 | by ( Jeff Marks | ) www.cnbc.com time to read: +3 min

Shortly after the opening bell, we will be selling 125 shares of Johnson & Johnson (JNJ) at roughly $171.26. Johnson & Johnson is trading up in the premarket, adding to a solid rally that kicked off when the health-care company reported earnings last Thursday . A split-off is when a company gives its shareholders the option to either keep shares or exchange some or all of their shares for new shares in the separated company. Johnson & Johnson confirmed this morning it will offer Kenvue shares at a 7% discount. A researcher works at the laboratory of the research and development plant of US multinational medical devices and pharmaceutical company Johnson & Johnson, in Val-de-Reuil, northwestern France Charly Triballeau | AFP | Getty Image

Persons: Johnson, Jim Cramer's, J, JNJ, it's, Jim Cramer, Jim, France Charly Triballeau Organizations: Johnson, Investors, CNBC, AFP, Getty Locations: California, Val, France

☆ ADNOC has upper hand in $30 bln plastics M&A
▼ + stars: | 2023-07-24 | by ( Karen Kwok | ) www.reuters.com time to read: +4 min

The complex ownership structure and the involvement of two governments make it intriguing to see who holds the whip hand. ADNOC owns 54% of Abu Dhabi-listed Borouge, while 36% of the same company is held by Borealis, with other investors accounting for the other 10%. Meanwhile ADNOC owns 25% of Borealis, while OMV holds the other 75%. Strip out Borouge's dividend, and Borealis would be worth $10 billion, Deutsche Bank reckons. ADNOC’s 63% Borouge stake and 25% Borealis stake are thus worth $14 billion and $2.5 billion respectively; OMV’s 27% Borouge stake and 75% Borealis holding are worth $6 billion and $7.5 billion.

Persons: ADNOC, OMV, Goldman Sachs, China's Sinopec, Saudi Arabia's SABIC, Abu Dhabi, Abu Dhabi’s, George Hay, Pranav Kiran Organizations: Reuters, Abu, Abu Dhabi National Oil Company, Borealis, Reuters Graphics Reuters, Deutsche Bank, Abu Dhabi National Oil Co, OMV, ADNOC, Thomson Locations: Abu Dhabi, Austrian, Borealis, Borouge, Saudi, India, Abu, Europe, Vienna, ADNOC

☆ Healthcare creating more opportunities for tech investors, says Harris Financial's Jamie Cox
▼ + stars: | 2023-07-21 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailHealthcare creating more opportunities for tech investors, says Harris Financial's Jamie CoxJamie Cox, Harris Financial Group managing partner, joins 'The Exchange' to discuss investment opportunities in medical devices, the intersection of healthcare and technology, and top picks in the medical tech space.

Persons: Harris, Jamie Cox Jamie Cox Organizations: Healthcare, Harris Financial Group

Shares of the electric car maker slid 3.1% in premarket trading after Musk's comments, even as Tesla beat quarterly profit estimates. Netflix (NFLX.O) fell 6.0% after the streaming video company's quarterly revenue forecast also fell short of estimates, while analysts said its new money-making ventures will take time to bring in returns. ET, Dow e-minis were up 61 points, or 0.17%, S&P 500 e-minis were down 4.25 points, or 0.09%, and Nasdaq 100 e-minis were down 98 points, or 0.61%. Investors also await weekly jobless claims data and existing home sales data for the month of June, due later in the day. Reporting by Bansari Mayur Kamdar and Johann M Cherian in Bengaluru; Editing by Dhanya Ann ThoppilOur Standards: The Thomson Reuters Trust Principles.

Persons: Tesla, Johnson, Elon Musk, markdowns, Joshua Warner, Dow, Goldman Sachs, chipmaker TSMC, Bansari Mayur Kamdar, Johann M, Dhanya Ann Thoppil Organizations: Netflix, Dow, Nasdaq, U.S . Federal Reserve, Enterprise, IBM, Dow e, Airlines, Investors, Thomson Locations: U.S, Bengaluru

☆ Dow eyes 9-day win streak as US stocks trade mixed after Tesla, Netflix earnings
▼ + stars: | 2023-07-20 | by ( Matthew Fox | ) www.businessinsider.com time to read: +1 min

US stocks traded mixed on Thursday as investors digested earnings results from Tesla and Netflix. Initial jobless claims fell to 228,000 last week, below economist estimates for 242,000. Tesla and Netflix stock fell 5% and 6%, respectively, in early Thursday trades, even though both companies beat analyst profit estimates. Johnson & Johnson traded slightly higher after the health care company beat earnings estimates and reported a surge in its medical devices business. Initial jobless claims fell to 228,000 last week, well below economist estimates for 242,000 jobless claims.

Persons: Johnson Organizations: Tesla, Netflix, Dow Jones, Service, Investors Locations: Wall, Silicon

☆ J&J expects cancer drugs, medical devices to drive growth in 2023
▼ + stars: | 2023-07-20 | by ( ) www.reuters.com time to read: +2 min

Shares of J&J, which recently spun off its consumer health unit to focus on drugs and medical devices, rose over 1% in premarket trading. The company expects sales at its pharmaceutical unit to grow more in the second half of 2023, compared with the first half. Quarterly sales of its multiple myeloma drug, Darzalex, were $2.43 billion, in line with Wall Street estimates, according to Refinitiv. Second-quarter sales for its medical device unit were $7.79 billion, topping estimates of $7.55 billion. J&J said it now expects adjusted 2023 profit of $10.70 to $10.80 per share, above estimates of $10.65 per share and its prior forecast of $10.60 to $10.70 per share.

Persons: Johnson, Stelara, J, J's, Bhanvi, Anil D'Silva Organizations: Johnson, Wall, Thomson Locations: Kenvue, Bengaluru

☆ J&J-spinoff Kenvue forecasts upbeat annual profit on strong self-care demand
▼ + stars: | 2023-07-20 | by ( ) www.reuters.com time to read: +2 min

Companies Kenvue Inc FollowNeutrogena Corporation FollowHaleon Plc Follow Show more companiesJuly 20 (Reuters) - Kenvue (KVUE.N), the former consumer health unit of Johnson & Johnson (JNJ.N), forecast full-year profit above Wall Street estimates on Thursday, betting on resilient demand for its skincare and self-care products such as Neutrogena and Tylenol. Kenvue, in its first results after being spun off from Johnson & Johnson in May, forecast full-year adjusted profit per share between $1.26 and $1.31. However, adjusted gross profit margin came in at 57.5%, compared to 59.3% a year earlier, dragged by a strong dollar and higher costs. Meanwhile, J&J raised its 2023 profit forecast on Thursday, banking on the strength in its medical devices business and demand for its cancer drugs such as Darzalex. Net sales rose 5.4% to $4.01 billion while adjusted profit per share came in at 32 cents.

Persons: Johnson, Haleon, J, Ananya Mariam Rajesh, Raghav, Devika Syamnath Organizations: Johnson, Wall, Thomson Locations: Bengaluru

CNN —The union representing pilots flying cargo planes for UPS say they will not cross picket lines if Teamsters strike next month, a spokesperson for the Independent Pilots Association confirmed to CNN. The heads of the two unions say in letters to each other that their support proved pivotal during a previous Teamsters strike in 1997. “No one wants a work stoppage, but should a legal IBT strike be initiated, you and the IBT can count on the IPA for support.”This does not mean UPS pilots are going on strike, rather there will be a work stoppage as they vow not to fly UPS cargo. Such as high value spare parts, pharmaceuticals, medical devices, anything of high value or high opportunity cost”Without UPS’ Pilots – the company will not be able to move anything from California to New York in a day. “This certainly is even more pressure on ups management to come to a deal with teamsters,” said Miller.

Persons: ”, Robert Travis, “, Jason Miller, Miller Organizations: CNN, UPS, Teamsters, Independent Pilots Association, “, Department of Supply Chain Management, Michigan State, Pilots, teamsters, UPS Air, FedEx Express Locations: California, New York

Abbott CEO Robert Ford said the great momentum in device and diagnostics sales during the quarter was due to improving market conditions in healthcare. Rival J&J's (JNJ.N) medical device segment also topped estimates, aided by a recovery in demand for medical procedures. Shares of rival medical device makers Medtronic (MDT.N) and Boston Scientific Corp (BSX.N) rose nearly 3%. Abbott clocked quarterly sales for its medical devices at $4.3 billion, with $1.3 billion coming from diabetes device Freestyle Libre, beating analysts' estimates of $4.10 billion. Abbott's adjusted profit of $1.08 per share in the quarter beat analysts' estimates of $1.05.

Persons: Robert Ford, J, Shagun Singh, Abbott, Khushi Mandowara, Pooja Desai Organizations: Abbott Laboratories, RBC Capital Markets, Boston Scientific Corp, U.S, Thomson Locations: Michigan, Bengaluru

☆ This high-yield bond fund with 'conservative' assets offers 10% in dividends
▼ + stars: | 2023-07-14 | by ( Ganesh Rao | ) www.cnbc.com time to read: +5 min

The Liontrust GF High Yield Bond fund has become notable thanks to one thing: A 10% dividend yield. "It's got a very high-quality credit rating, I would argue," said Donald Phillips, one of the portfolio managers behind the fund. fund manager, Liontrust GF High Yield Bond fund Donald Phillips It also holds debt considered relatively riskier by credit rating agencies but one that Phillips believes has been mispriced. The value of a credit default swap increases when the risk of default rises. He highlighted that their fund yields higher returns and charges lower fees than many similar index ETFs.

Persons: It's, Donald Phillips, Phillips, Fortescue, it's, Biden Organizations: Fortescue Metals, Liontrust, ETF Locations: Europe, CeramTec

Tom Schroeder, the whistleblower accusing Medtronic of a kickback scheme, left, is interviewed by Morgan Brennan, in Kansas City, Missouri. Schroeder said rumors circulated that Medtronic sales representatives were bribing VA staff to purchase an excessive amount of the company's inventory. The veterans hospital purchased more devices than some of the largest veterans medical facilities, according to data the VA's investigation gathered. Medtronic also said that Schroeder has "admitted under oath that he has no firsthand knowledge of any problematic procedure involving Medtronic devices." Douglas Winger, one of the Medtronic sales representatives named as a defendant in Schroeder's lawsuit, won a Medtronic President's Club award in 2016 for his sales.

Persons: Tom Schroeder, Schroeder, Becton Dickinson, Medtronic, Morgan Brennan, Schroder, Boua Xiong, Robert J, texted, Rick Ament, Ament, filet mignon, …, I'm, Brendan Donelon, Donelon, CNBC Donelon, Xiong, Douglas Winger, Winger, Kim Hodgson, Hodgson, Dole, ProPublica, John Laird Organizations: Inc, CNBC, Dole Veterans Affairs Medical Center, Dole VA, Department of Veterans Affairs, United, VA's, Department of Justice, Covidien, Dole, Medtronic, Society for Vascular, Drug Administration, FDA Locations: Kansas, United States, Kansas City , Missouri, Dublin, Ireland, Medtronic's, Wichita ., Dole, Covidien, Medtronic, Dole VA

☆ Wall St Week Ahead As earnings loom, investors weigh recession resilience
▼ + stars: | 2023-07-07 | by ( David Randall | ) www.reuters.com time to read: +5 min

The financials sector is down 2%, while energy is nearly 9% lower. These unloved sectors are growing attractive to investors increasingly torn over whether a long-feared U.S. recession will ever materialize. Quincy Krosby, chief global strategist for LPL Financial noted a "tug of war" in the market over the likelihood of a recession. The healthcare sector trades at a forward price-to-earnings ratio of 17.6, well below the 20.1 ratio of the broad S&P 500. Yet a continued rally in megacaps will likely stretch their valuations further, prompting some investors to rotate toward healthcare and financials, LPL Financial's Krosby said.

Persons: Goldman Sachs, Quincy Krosby, Sameer Samana, Max Wasserman, Financials, Tom Ognar, Morgan Stanley, John Quealy, Financial's Krosby, David Randall, Megan Davies, Michelle Price, Richard Chang Organizations: YORK, Global, BofA, Commerce Department, LPL Financial, Reserve, Wells, Wells Fargo Investment Institute, FINANCIALS, Miramar Capital, Abbott Laboratories, Allspring Global Investments, LPL Financial Holdings Inc, Trillium Asset Management, Russell, Thomson Locations: U.S, BlackRock, Wells Fargo, megacaps

Recessions haven't always resulted in declining stock markets, and good opportunities can be found amid them. Sectors for recession naysayersThe best sectors for recession disbelievers are the most economically sensitive ones: industrials, materials and financials. Well-positioned companies with good growth prospects currently include: Corteva, Dow Chemical, Ecolab, Linde plc, Martin Marietta Materials, Nucor Corp., PPG Industries and Sherwin-Williams. Currently buyable names include: Campbell Soup Co., General Mills, The Hershey Co., Kellogg's, Kimberly-Clark Corp., Kroger, Procter & Gamble and Walmart. Sector names with reasonable risk levels and good growth prospects include: Vertex Pharmaceuticals, IDEXX Laboratories, DaVita Inc., Veeva Systems Inc., IQVIA Holdings Inc., Cigna Group and Zoetis Inc.

Persons: Sherwin, Williams, Mayur, Martin Marietta, JPMorgan Chase, Rowe Price, Willis Towers Watson, Campbell, General Mills, Clark, Willie B, Thomas, Digitalvision Organizations: Westend61, University of Michigan Consumer, Investors, Westinghouse Air Brake Co, Cummins Inc, CSX, Emerson Electric, Otis Worldwide, Carrier, Caterpillar, Honeywell, Illinois Tool, Lockheed Martin Corp, Dow Chemical, Ecolab, Linde plc, Martin, Martin Marietta Materials, Nucor Corp, PPG Industries, XLF, JPMorgan, Rowe Price Group Inc, American International Group, Allstate, The, McLennan, Sectors, Co, Hershey Co, Clark Corp, Kroger, Procter, Gamble, Walmart, Getty Images Health, iShares U.S, Medical Devices, Vertex Pharmaceuticals, IDEXX Laboratories, DaVita Inc, Veeva Systems Inc, IQVIA Holdings Inc, Cigna, Zoetis Inc Locations: American, The Hartford, Marsh, Kimberly

☆ AI could solve the engineering brain drain, a new study says
▼ + stars: | 2023-06-22 | by ( Aaron Mok | ) www.businessinsider.com time to read: +3 min

97% of the decision makers who responded to the survey say a shortage of mechanical engineering talent is on its way. "Unfortunately, there are not enough students graduating with engineering degrees to meet this growing demand," Evans told Insider over email. 97% of respondents believe AI will impact product development and manufacturing tasks like quality control and product design. 62% of decision makers say they are training their existing workers in AI tech to improve their workflows. Now, it's only a matter of time before the manufacturing industry adopts AI.

Persons: Fictiv, Dave Evans, Evans Organizations: Engineers

☆ Another Chinese company scraps GDR plan as listing rules tighten
▼ + stars: | 2023-06-20 | by ( ) www.reuters.com time to read: +1 min

SHANGHAI/SINGAPORE, June 20 (Reuters) - Bethel Automotive Safety Systems Co (603596.SS) scrapped plans to issue Global Depository Receipts (GDR), citing changes in domestic and overseas capital market conditions, after China tightened rules for GDR listings. The new GDR rules by China's securities regulator last month put curbs on the use of proceeds and made issuances liable to national security reviews, potentially dampening Chinese companies' interest in listing in Europe, bankers said. The Shanghai-listed automotive braking system manufacturer said on Monday it decided to terminate the GDR plan after considering its financial and operational situations. Earlier this month, Shenzhen-listed medical devices maker Jiangsu Yuyue Medical Equipment & Supply Co (002223.SZ) cancelled a proposed Swiss GDR offering plan, citing changes in market conditions. Reporting by Jason Xue in Shanghai and Tom Westbrook in Singapore; Editing by Varun H KOur Standards: The Thomson Reuters Trust Principles.

Persons: Bethel, Jason Xue, Tom Westbrook, Varun Organizations: Bethel Automotive Safety Systems, SIX, SIX Swiss Exchange, Supply, Thomson Locations: SHANGHAI, SINGAPORE, Bethel, China, GDR, Europe, Shanghai, SIX Swiss, Shenzhen, Jiangsu, Swiss GDR, Zurich, London, U.S, Singapore

The reshoring trend is bringing manufacturing back into the U.S., putting the need for robots and automation at the forefront of the building boom. But with a tight labor market, companies are incorporating more automation and robotics into these brand new factories. Another robotics company Daryanani picked was Azenta . Sakraida said it could see upside as it gradually exposes itself more to the reshoring trend. It's working toward becoming a pure-play automation company," Sakraida said.

Persons: Jonathan Sakraida, reshoring, Carol Schleif, BMO's, Amit Daryanani, Daryanani, chipmakers, Morgan Stanley, industrials, Jonathan Coleman, Janus Henderson, Sakraida, Chris Snyder, Rockwell, — CNBC's Michael Bloom Organizations: UBS, Labor, BMO Family, HP, Janus Henderson Investors, Lincoln Electric, Rockwell Automation, ROK, Emerson Electric, Emerson Locations: U.S

☆ Medical spending is rising. Here’s why that could be bad news for the biggest health-care ETFs
▼ + stars: | 2023-06-15 | by ( Jesse Pound | In Jesse-Pound | ) www.cnbc.com time to read: +2 min

A warning from UnitedHealth Group executives Wednesday that demand for medical services was rising sent insurance stocks tumbling and, in turn, hit investors who bet on health care. The biggest health-care exchange-traded fund, the $41 billion Health Care Select Sector SPDR Fund (XLV) , lost 1% Wednesday. The $17 billion Vanguard Health Care ETF (VHT) also fell about 1%. XLV 5D mountain The XLV was dragged down by insurance stocks on Wednesday. Some Wall Street analysts said the dramatic sell-off in typically stodgy insurance stocks could prove to be a buying opportunity.

Persons: John Franklin Rex, Rex, that's, Cantor Fitzgerald, Sarah James, — CNBC's Michael Bloom Organizations: UnitedHealth Group, Humana, CVS Health, Health Care, CVS, Devices, Abbott Laboratories

☆ Using video games as medical treatments seemed promising, but a stunning failure raises questions about the future of digital therapeutics
▼ + stars: | 2023-06-07 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +7 min

With digital therapeutics' trailblazers in jeopardy, experts think more failures are on the horizon. Covering digital therapeutics hasn't been easyInsurers, the ultimate gatekeepers in healthcare, have been slow to warm to the idea of reimbursing prescription digital therapeutics. Plus, most digital therapeutics don't integrate with electronic-health-records systems, making it difficult for clinicians to track their patients' progress. Senators reintroduced a bill in March that would guarantee Medicare reimbursement for prescription digital therapeutics. Want to tell us about your experience with digital therapeutics?

Persons: Pear, It's, Akili, Jeffrey Abraham, Rick Bartels, Bartels, Corey McCann, Matt Stoudt, Stoudt, Matthew Stoudt, keener, we'll, that's, Abraham, Rebecca Torrence Organizations: Morning, Pear Therapeutics, Food and Drug Administration, FDA, Digital Therapeutics, Pear, Centers, Medicare, Services, Senators, CMS

Search resuls for: "Medical Devices"

25 mentions found